These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 11214765)

  • 1. Interaction between angiotensin-converting enzyme inhibitors and aspirin: a review.
    Meune C; Mahe I; Mourad JJ; Simoneau G; Knellwolf AL; Bergmann JF; Caulin C
    Eur J Clin Pharmacol; 2000 Dec; 56(9-10):609-20. PubMed ID: 11214765
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction between aspirin and angiotensin-converting enzyme inhibitors: should they be used together in older adults with heart failure?
    Ahmed A
    J Am Geriatr Soc; 2002 Jul; 50(7):1293-6. PubMed ID: 12133028
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction between aspirin and ACE inhibitors in patients with heart failure.
    Mahé I; Meune C; Diemer M; Caulin C; Bergmann JF
    Drug Saf; 2001; 24(3):167-82. PubMed ID: 11347721
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aspirin-angiotensin-converting enzyme inhibitor coadministration and mortality in patients with heart failure: a dose-related adverse effect of aspirin.
    Guazzi M; Brambilla R; Reina G; Tumminello G; Guazzi MD
    Arch Intern Med; 2003 Jul; 163(13):1574-9. PubMed ID: 12860580
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does aspirin attenuate the effect of angiotensin-converting enzyme inhibitors in hypertension or heart failure?
    Cleland JG; John J; Houghton T
    Curr Opin Nephrol Hypertens; 2001 Sep; 10(5):625-31. PubMed ID: 11496056
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Use of aspirin in patients taking angiotensin converting enzyme inhibitors].
    Altin T; Kiliçkap M
    Anadolu Kardiyol Derg; 2007 Dec; 7 Suppl 2():14-9. PubMed ID: 18160362
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Aspirin, angiotensin converting enzyme inhibitors and cardiac insufficiency].
    de Groote P; Aumégeat V; Meurice T; Millaire A; Lamblin N; Lablanche JM
    Arch Mal Coeur Vaiss; 2000 Feb; 93(2):167-71. PubMed ID: 10830093
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers on all-cause mortality, cardiovascular deaths, and cardiovascular events in patients with diabetes mellitus: a meta-analysis.
    Cheng J; Zhang W; Zhang X; Han F; Li X; He X; Li Q; Chen J
    JAMA Intern Med; 2014 May; 174(5):773-85. PubMed ID: 24687000
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Update on the interaction between aspirin and angiotensin-converting enzyme inhibitors.
    Nawarskas JJ; Spinler SA
    Pharmacotherapy; 2000 Jun; 20(6):698-710. PubMed ID: 10853626
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does aspirin use adversely influence intermediate-term postdischarge outcomes for hospitalized patients who are treated with angiotensin-converting enzyme inhibitors or angiotensin receptor blockers? Findings from Organized Program to Facilitate Life-Saving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF).
    Levy PD; Nandyal D; Welch RD; Sun JL; Pieper K; Ghali JK; Fonarow GC; Gheorghiade M; O'Connor CM
    Am Heart J; 2010 Feb; 159(2):222-230.e2. PubMed ID: 20152220
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aspirin alters arterial function in patients with chronic heart failure treated with ACE inhibitors: a dose-mediated deleterious effect.
    Meune C; Mahé I; Mourad JJ; Cohen-Solal A; Levy B; Kevorkian JP; Jondeau G; Habib A; Lebret M; Knellwolf AL; Simoneau G; Caulin C; Bergmann JF
    Eur J Heart Fail; 2003 Jun; 5(3):271-9. PubMed ID: 12798824
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does aspirin attenuate the beneficial effects of angiotensin-converting enzyme inhibition in heart failure?
    Stys T; Lawson WE; Smaldone GC; Stys A
    Arch Intern Med; 2000 May; 160(10):1409-13. PubMed ID: 10826452
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction between cyclooxygenase and the renin-angiotensin-aldosterone system: rationale and clinical relevance.
    Meune C; Mourad JJ; Bergmann JF; Spaulding C
    J Renin Angiotensin Aldosterone Syst; 2003 Sep; 4(3):149-54. PubMed ID: 14608518
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does aspirin interfere with the therapeutic efficacy of angiotensin-converting enzyme inhibitors in hypertension or congestive heart failure?
    Nawarskas JJ; Spinler SA
    Pharmacotherapy; 1998; 18(5):1041-52. PubMed ID: 9758314
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical effects of early angiotensin-converting enzyme inhibitor treatment for acute myocardial infarction are similar in the presence and absence of aspirin: systematic overview of individual data from 96,712 randomized patients. Angiotensin-converting Enzyme Inhibitor Myocardial Infarction Collaborative Group.
    Latini R; Tognoni G; Maggioni AP; Baigent C; Braunwald E; Chen ZM; Collins R; Flather M; Franzosi MG; Kjekshus J; Køber L; Liu LS; Peto R; Pfeffer M; Pizzetti F; Santoro E; Sleight P; Swedberg K; Tavazzi L; Wang W; Yusuf S
    J Am Coll Cardiol; 2000 Jun; 35(7):1801-7. PubMed ID: 10841227
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The antagonistic effect of aspirin on the expression of prostaglandin participation in the antihypertensive activity of ACE inhibitors].
    Alimento M; Campodonico J; Santambrogio G; Rossi M; Trabattoni D; Celeste F; Guazzi M
    Cardiologia; 1997 Jun; 42(6):605-10. PubMed ID: 9289376
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantifying the interaction between angiotensin-converting enzyme inhibitors and aspirin: are we using the right method?
    Etminan M
    Pharmacotherapy; 2001 Oct; 21(10):1247-9. PubMed ID: 11601671
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers on cardiovascular events in patients with heart failure: a meta-analysis of randomized controlled trials.
    Tai C; Gan T; Zou L; Sun Y; Zhang Y; Chen W; Li J; Zhang J; Xu Y; Lu H; Xu D
    BMC Cardiovasc Disord; 2017 Oct; 17(1):257. PubMed ID: 28982370
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angioedema related to Angiotensin inhibitors.
    Knecht SE; Dunn SP; Macaulay TE
    J Pharm Pract; 2014 Oct; 27(5):461-5. PubMed ID: 25124378
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angiotensin-converting enzyme inhibitors (ACEIs), not angiotensin receptor blockers (ARBs), are preferred and effective mode of therapy in high cardiovascular risk patients.
    Vijan SG
    J Indian Med Assoc; 2009 Mar; 107(3):178-82. PubMed ID: 19810392
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.